Wockhardt’s Q3 consolidated net surges over 50%

14 Feb 2012 Evaluate

Drug firm, Wockhardt’s consolidated net profit rose by 50.21% to Rs 212.81 crore in the third quarter ended December 31, 2011, on the back of strong sales in the US market. The company had posted a net profit of Rs 141.67 crore for the corresponding period last fiscal.

Net sales of the company rose by 27.12% to Rs 1,208.67 crore in the quarter ended December 31, 2011, from Rs 950.80 crore in the same period last fiscal.

On a standalone basis, the company posted a net profit of Rs 116.16 crore for the third quarter, as against Rs 66.66 crore for the same period last financial year.

Wockhardt Share Price

1435.00 -1.95 (-0.14%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×